Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juuli Raivola

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Enzymology|May 7, 2022
Cellular thermal shift assay (CETSA) for determining the drug binding affinity using Ba/F3 clones stably expressing receptor pseudokinasesHanna Karvonen, Juuli Raivola, Daniela Ungureanu
Cancers|January 2, 2020
Characterization of JAK1 Pseudokinase Domain in Cytokine SignalingJuuli Raivola, Teemu Haikarainen, Olli Silvennoinen
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 1, 2019
Selective JAKinibs: Prospects in Inflammatory and Autoimmune DiseasesAnniina T Virtanen, Teemu Haikarainen, Juuli Raivola, et al.
Cancers|March 6, 2021
Janus Kinases in LeukemiaJuuli Raivola, Teemu Haikarainen, Bobin George Abraham, et al.
Cytokine|April 25, 2018
The regulation of JAKs in cytokine signaling and its breakdown in diseaseHenrik M Hammarén, Anniina T Virtanen, Juuli Raivola, et al.
Frontiers in Oncology|December 19, 2018
Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase DomainJuuli Raivola, Henrik M Hammarén, Anniina T Virtanen, et al.
Nature Chemical Biology|November 1, 2024
A multiplex single-cell RNA-Seq pharmacotranscriptomics pipeline for drug discoveryAlice Dini, Harlan Barker, Emilia Piki, et al.
Cancers|August 7, 2021
Evaluating Targeted Therapies in Ovarian Cancer Metabolism: Novel Role for PCSK9 and Second Generation mTOR InhibitorsDafne Jacome Sanz, Juuli Raivola, Hanna Karvonen, et al.
Cellular and Molecular Life Sciences : CMLS|May 3, 2022
New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactomeJuuli Raivola, Alice Dini, Kari Salokas, et al.
Molecular Therapy. Oncology|December 5, 2024
Molecular and functional profiling of primary normal ovarian cells defines insights into cancer development and drug responsesEmilia Piki, Alice Dini, Frida Rantanen, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Enzymology|May 7, 2022
Cellular thermal shift assay (CETSA) for determining the drug binding affinity using Ba/F3 clones stably expressing receptor pseudokinasesHanna Karvonen, Juuli Raivola, Daniela Ungureanu
Cancers|January 2, 2020
Characterization of JAK1 Pseudokinase Domain in Cytokine SignalingJuuli Raivola, Teemu Haikarainen, Olli Silvennoinen
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 1, 2019
Selective JAKinibs: Prospects in Inflammatory and Autoimmune DiseasesAnniina T Virtanen, Teemu Haikarainen, Juuli Raivola, et al.
Cancers|March 6, 2021
Janus Kinases in LeukemiaJuuli Raivola, Teemu Haikarainen, Bobin George Abraham, et al.
Cytokine|April 25, 2018
The regulation of JAKs in cytokine signaling and its breakdown in diseaseHenrik M Hammarén, Anniina T Virtanen, Juuli Raivola, et al.
Frontiers in Oncology|December 19, 2018
Hyperactivation of Oncogenic JAK3 Mutants Depend on ATP Binding to the Pseudokinase DomainJuuli Raivola, Henrik M Hammarén, Anniina T Virtanen, et al.
Nature Chemical Biology|November 1, 2024
A multiplex single-cell RNA-Seq pharmacotranscriptomics pipeline for drug discoveryAlice Dini, Harlan Barker, Emilia Piki, et al.
Cancers|August 7, 2021
Evaluating Targeted Therapies in Ovarian Cancer Metabolism: Novel Role for PCSK9 and Second Generation mTOR InhibitorsDafne Jacome Sanz, Juuli Raivola, Hanna Karvonen, et al.
Cellular and Molecular Life Sciences : CMLS|May 3, 2022
New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactomeJuuli Raivola, Alice Dini, Kari Salokas, et al.
Molecular Therapy. Oncology|December 5, 2024
Molecular and functional profiling of primary normal ovarian cells defines insights into cancer development and drug responsesEmilia Piki, Alice Dini, Frida Rantanen, et al.
Pageof 2